aztreonam has been researched along with Aging in 2 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aztreonam (30 mg/kg of body weight) was administered intravenously over 3 min every 12 h to 30 preterm neonates divided into two groups according to gestational age (mean age for group A was less than 30 weeks and mean age for group B was greater than 30 weeks) and birth weight (mean weight for group A was less than 1,500 g and mean weight for group B was greater than 1,500 g)." | 3.68 | Pharmacokinetics and renal tolerance of aztreonam in premature infants. ( Benoni, G; Cuzzolin, L; Fanos, V; Padovani, EM; Zambreri, D, 1991) |
| "12 L/h/kg), and terminal half-life is 1." | 2.37 | Clinical pharmacokinetics of aztreonam. ( Mattie, H, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuzzolin, L | 1 |
| Fanos, V | 1 |
| Zambreri, D | 1 |
| Padovani, EM | 1 |
| Benoni, G | 1 |
| Mattie, H | 1 |
1 review available for aztreonam and Aging
| Article | Year |
|---|---|
Clinical pharmacokinetics of aztreonam.
Topics: Aging; Aztreonam; Bacterial Infections; Drug Administration Routes; Humans; Kidney; Kidney Diseases; | 1988 |
1 other study available for aztreonam and Aging
| Article | Year |
|---|---|
Pharmacokinetics and renal tolerance of aztreonam in premature infants.
Topics: Acetylglucosaminidase; Aging; Aztreonam; Birth Weight; Gestational Age; Half-Life; Humans; Infant, N | 1991 |